For the Inventor, By the Inventor

Enter assignee name

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

USPTO Granted Patents = 13

EPO Patents = 1

Trademarks = 1

Forward Citations = 11

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Qian Zhao (4 out of 14 patents)

Yuefeng Lu (4 out of 11 patents)

Jian-Feng Lu (4 out of 11 patents)

4. Huilei Yu (3 out of 3 patents)

5. Jianhe Xu (3 out of 4 patents)

6. Hongyu Chen (3 out of 3 patents)

7. Yan Mei Zhang (3 out of 37 patents)

8. Shuhui Chen (2 out of 197 patents)

9. Charles Z Ding (2 out of 50 patents)

10. Lihong Hu (2 out of 29 patents)

11. Xiangfeng Chen (2 out of 2 patents)

12. Min Sun (2 out of 2 patents)

13. Jiang Pan (2 out of 3 patents)

14. Kurt Shanebeck (2 out of 4 patents)

15. Lu Li (2 out of 3 patents)

13 patents: Sort by Forward Citations

1. 12325695 - 5-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitor (2025-06-10),

2. 12122780 - Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor (2024-10-22),

3. 11746147 - Angiopoietin 2, VEGF dual antagonists (2023-09-05),

4. 11505618 - Antibodies and methods for making and using the same (2022-11-22),

5. 11345900 - Monooxygenase and use in preparation of optically pure sulfoxide (2022-05-31),

6. 11187683 - Dexrazoxane analytical method (2021-11-30),

7. 11078184 - Dexrabeprazole sodium compound and pharmaceutical composition thereof (2021-08-03),

8. 11001866 - Burkholderia and applications thereof (2021-05-11),

9. 10966993 - Pharmaceutical composition comprising a sulfonylurea drug and preparation method thereof (2021-04-06),

10. 10787651 - Bradyrhizobium monooxygenase and use thereof for preparation of chiral sulfoxide (2020-09-29),

11. 10752652 - Method for preparing a ß-nucleoside compound (2020-08-25),

12. 10654922 - Angiopoietin 2, VEGF dual antagonists (2020-05-19),

13. 10077308 - PD-L1 specific monoclonal antibodies for disease treatment and diagnosis (2018-09-18),

Jiangsu Aosaikang Pharmaceutical Co., Ltd. is a leading pharmaceutical company in China, specializing in the research, development, and production of high-quality pharmaceutical products. With a strong commitment to innovation and quality, the company has established itself as a trusted provider of medical solutions for various health conditions. Aosaikang Pharmaceutical is dedicated to improving the lives of patients through cutting-edge pharmaceutical products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#28 in Nanjing

#1,948 in China

#43,679 in the World

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Forward Citations = 11

43 inventors:

Qian Zhao (4 out of 14 patents)

Yuefeng Lu (4 out of 11 patents)

Jian-Feng Lu (4 out of 11 patents)

4. Huilei Yu (3 out of 3 patents)

5. Jianhe Xu (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…